Linical

Linical Co., Ltd. is a publicly traded, Japan-headquartered CRO with a mission to be a quality-driven, strategic partner that accelerates clinical development for its biopharma clients. The company has built a strong reputation through its 'right-sized' operational model, balancing personalized service with a global footprint across over 30 countries. Key achievements include managing over 600 studies in five years, maintaining an 85%+ client retention rate, and exceeding enrollment goals in more than 80% of its studies.

Linical's platform is its integrated suite of clinical trial service offerings, operational methodologies, and global infrastructure, emphasizing therapeutic expertise, proactive planning, and a 'gateway to global' execution model to drive trial efficiency and quality for clients.

Linical competes in the mid-tier segment of the global CRO market, differentiating itself as a 'right-sized,' partnership-focused alternative to large, impersonal CROs and smaller niche players. Its deep therapeutic expertise and strong Asia-Pacific presence are core competitive advantages.